Company intelligence / Profile preview

Artur Salgado

Ownership: Private
Development stage: Other

Overview

Artur Salgado is a leading Portuguese distributor and manufacturer of medical devices for orthopedics and trauma. Since 2021, the company has been certified to design, develop, and produce medical devices for bone regeneration. Its flagship product, AdvanCore—a synthetic beta-tricalcium phosphate ceramic—supports osteogenesis in orthopedic, trauma, and maxillofacial surgeries. AdvanCore is biocompatible with high porosity for vascularization and typically resorbs within 12 months after implantation.

Therapeutic areas: OtherRheumatologyEndocrinology
Modalities: DeviceSynthetic bone substitute (beta-tricalcium phosphate ceramic)
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Artur Salgado.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Artur Salgado.

Explore the full profile